ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the fourth quarter and full-year ended Jan. 2, 2016.
Fourth quarter 2015 highlights:
• Neuromodulation sales increased 9 percent on a constant-currency basis over the fourth quarter of 2014